← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksPHGERevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

PHGE logoBiomX Inc. (PHGE) Revenue History

Annual and quarterly revenue from 2017 to 2025

TTM Revenue
$0
0
YoY Growth
-
Latest Quarter
$0
Q4 2025
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$0 ()

Loading revenue history...

PHGE Revenue Growth

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Peak Annual Revenue$0 (0)

Download Historical Data

9 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

PHGE Revenue Analysis (2017–2025)

As of May 8, 2026, BiomX Inc. (PHGE) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.

Looking at the longer-term picture, PHGE's historical revenue data shows various trends over time.

When compared to Healthcare sector peers including LSTA (-83.0% YoY), ASMB (+95.6% YoY), and CRSP (-88.9% YoY). Compare PHGE vs LSTA →

PHGE Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
PHGE logoPHGECurrent$0---
LSTA logoLSTA$170,000-83.0%--10711.2%
ASMB logoASMB$72M+95.6%-1.8%-16.8%
CRSP logoCRSP$4M-88.9%+37.3%-16191.4%
Best in groupLowest in group

PHGE Historical Revenue Data (2017–2025)

Showing 9 of 9 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$0-$-2,922,000-$-32,909,999-
2024$0-$-1,803,000-$-39,027,000-
2023$0-$-871,000-$-27,685,000-
2022$0-$0-$-27,219,000-
2021$0-$0-$-35,462,000-
2020$0-$0-$-30,258,000-
2019$0-$0-$-22,207,000-
2018$0-$-210,000-$-13,141,000-
2017$0-$-95,000-$-7,372,000-

See PHGE's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is PHGE Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare PHGE vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

PHGE — Frequently Asked Questions

Quick answers to the most common questions about buying PHGE stock.

Is PHGE's revenue growth accelerating or slowing?

PHGE TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is PHGE's long-term revenue growth rate?

BiomX Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is PHGE's revenue distributed by segment?

PHGE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

PHGE Revenue Over Time (2017–2025)